The global regulatory affairs outsourcing market was valued at US$ 4,236.2 Mn in 2017 and is expected to expand at a CAGR of 13.1% from 2018 to 2026, according to a new report published by Transparency Market Research (TMR) titled “Regulatory Affairs Outsourcing Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2018–2026.” North America region is expected to hold the dominant revenue share, with the market in the region expanding at a CAGR of above 10%. The global regulatory affairs outsourcing market is mainly driven by growing stringent government regulations and automation in regulatory affairs.
Request Brochure of Report – https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=3528
Improving return on investment by timely approvals, and rise in research and development activities especially in life sciences industry globally driving the market
The pharmaceutical industry has been constantly evolving as traditional methods of drug development continue to expand. There is constant pressure on pharmaceutical and medical devices industry to reduce cost of prescription drugs and critical healthcare devices. As companies continue to expand their business in the global market, timely clinical approvals from regulators is becoming key to their success. Toward this end, biopharmaceutical and medical device companies have strengthened their in-house regulatory department or outsourced this function to regulatory affairs consulting firms. As pressure to improve return on investment grows, limitation on finding experienced workforce especially in smaller companies for internal R&D, and reduced drug development timeline with increasing stringent government regulations have led to the growth of the regulatory affairs market globally. Also, increasing research and development activities, along with patent expirations, have been identified as major factors fueling the growth of the regulatory affairs outsourcing market.
Request for Custom Research – https://www.transparencymarketresearch.com/sample/sample.php?flag=CR&rep_id=51408
Growing adoption of regulatory writing and publishing a crucial factor in the expansion of the market
The regulatory affairs outsourcing market can be segmented based on service and region. The service segment is classified into regulatory submissions; clinical trial applications and product registrations; regulatory writing and publishing; regulatory consulting and legal representation;and others. The others segment includes maintenance and post-marketing surveillance. The growth in regulatory writing and publishing is attributed to the increased frequency of outsourcing medical writing, clinical trial summaries, drafting of informed consent forms and other services. Also, the regulatory consulting and legal representation segment is expected to expand at the highest CAGR during the forecast period. This is due to the increasing need for the consultation specifically with respect to country wise filing strategies and for gap analysis.
Request for Analysis of COVID19 Impact on Regulatory Affairs Outsourcing Market – https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=3528
North America dominance of the regulatory affairs outsourcing market projected to continue
In terms of geography, the regulatory affairs outsourcing market is segmented into five regions namely, North America, South America, Middle East &Africa, Asia Pacific, and Europe. Among these, North Americais expected to hold a major share of above 40% of the market in terms of revenue, by 2026. The significant healthcare and pharmaceutical spend in the U.S., large number of clinical trials in the region, and increased R&D spending in the life sciences industry are responsible for higher market share. However, the market in Asia Pacific is expected to grow at the highest CAGR during the forecast period. Increasing preference by majority of the pharmaceutical companies toward business expansion in countries such as India and China due to a favorable business environment would further support the growth of the regulatory affairs outsourcing market in these countries
Buy Regulatory Affairs Outsourcing Market Report – https://www.transparencymarketresearch.com/checkout.php?rep_id=3528<ype=S
Major players operating in the global regulatory affairs outsourcing market include PAREXEL International Corporation, WuXi AppTec, IQVIA Holdings Inc., Accell Clinical Research LLC, Clinilabs Inc., Criterium, Inc., Pharmaceutical Product Development, (PPD) LLC, Promedica International, Charles River Laboratories International, Inc., ICON plc., BlueReg Group, Covance, Inc., Dr. Regenold GmbH,FMD K&L, Genpact Limited, ProductLife S.A Group., Intertek Group plc, Kinapse Ltd, Medpace, Inc., Navitas Life Sciences, PharmaLex GmbH, PRA Health Sciences, Inc., Syneos Health, Inc., and Verisk 3E. These players are focusing on acquisitions and new strategic collaborations in order to increase their market share in the global regulatory affairs outsourcing market.
Transparency Market Research is a global market intelligence company providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for several decision makers. Our experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.
Our data repository is continuously updated and revised by a team of research experts so that it always reflects latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.
Transparency Market Research,
90 Sate Street, Suite 700,
Albany, NY 12207
USA – Canada Toll Free: 866-552-3453